A Comparative Clinical Study To Evaluate The Efficacy Of Agasti Modak And Sitopaladi Churna In The Management Of Kaphaj Kasa In Pediatric Age Group

Physiologically, kaphaj dosha is more common in balya-awastha and might result in kaphaj kasa and other kaphaj vyadhi. This is among the most prevalent illnesses that impact Pranvaha shrotas and the child’s overall health. An acute respiratory tract infection is linked to upper respiratory disorders. The study includes pediatric patients diagnosed with Kaphaj Kasa, who are randomly divided into two groups

Group A (Trial group) will receive Agasti Modak in oral form, three times daily after meals for 10 days. Dose will be adjusted as per age: 2.5 – 3.5 g (3 – 5 yrs), 3.5 – 5.5 g (6 – 8 yrs), and 4.5 – 6.5 g (9 – 11 yrs).

Group B (Control group) will receive Sitopaladi Churna with Madhu and Ghrita three times daily after meals for 10 days, with age-appropriate dose ranging from 0.2– 0.6 g (3-5 yrs) , 0.4 - 1 g (6-8 ys) and 0.5-1.3 g (9-11yrs)

Follow-up will be done on the 11th day after treatment completion. Assessment will be based on subjective and objective parameters related to the severity and frequency of cough and associated symptoms. Dietary advice (Pathya-Apathya) will be followed during the study.The efficacy of the treatments will be evaluated based on clinical symptoms such as cough frequency, sputum production, and overall improvement in respiratory function. The study seeks to determine which formulation provides better relief and faster recovery, thereby contributing to evidence-based Ayurvedic management of respiratory disorders in children.

Agasti Modak is a classical Ayurvedic formulation mentioned in Bhaisajya Ratnawali It is indicated in Kaphaja Kasa (cough). Agasti modak have seven ingredients they act as bronchodilator, expectorant, and immunomodulatory effects.

Hence, it helps in reducing frequency and severity of cough, relieving airway obstruction, and promoting clearance of respiratory secretions.